List of Nymalize drug patents

Nymalize is owned by Azurity.

Nymalize contains Nimodipine.

Nymalize has a total of 7 drug patents out of which 0 drug patents have expired.

Nymalize was authorised for market use on 10 May, 2013.

Nymalize is available in solution;oral dosage forms.

Nymalize can be used as a method for the improvement of neurological outcome by reducing the incidence and severity of ischemic deficits in adult patients with subarachnoid hemorrhage (sah) from ruptured intracranial berry aneurysms.

The generics of Nymalize are possible to be released after 16 April, 2038.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7070581 AZURITY Dispenser for medicaments and method and apparatus for making same
Jun, 2023

(4 months from now)

US8517997 AZURITY Dispenser for medicaments and method and apparatus for making same
May, 2024

(1 year, 3 months from now)

US10576070 AZURITY Non-aqueous liquid nimodipine compositions
Apr, 2038

(15 years from now)

US11207306 AZURITY Non-aqueous liquid nimodipine compositions
Apr, 2038

(15 years from now)

US10342787 AZURITY Non-aqueous liquid nimodipine compositions
Apr, 2038

(15 years from now)

US11413277 AZURITY Non-aqueous liquid nimodipine compositions
Apr, 2038

(15 years from now)

US11517563 AZURITY NA
Apr, 2038

(15 years from now)

Drugs and Companies using NIMODIPINE ingredient

Market Authorisation Date: 10 May, 2013

Treatment: A method for the improvement of neurological outcome by reducing the incidence and severity of ischemic deficits in adult patients with subarachnoid hemorrhage (sah) from ruptured intracranial berry aneurysms

Dosage: SOLUTION;ORAL

How can I launch a generic of NYMALIZE before it's patent expiration?
More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in